This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Olink Holding 배당금

배당금 기준 확인 0/6

Olink Holding 배당금을 지급한 기록이 없습니다.

주요 정보

n/a

배당 수익률

n/a

지급 비율

업계 평균 수익률	0.3%
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
주당 순이익	-US$0.27
배당 수익률 예측	n/a

최근 배당금 업데이트

업데이트 없음

Recent updates

Revenues Tell The Story For Olink Holding AB (publ) (NASDAQ:OLK)

Jun 21

Olink Holding AB (publ) (NASDAQ:OLK) Just Reported And Analysts Have Been Cutting Their Estimates

Mar 28

Is It Time To Consider Buying Olink Holding AB (publ) (NASDAQ:OLK)?

Oct 19

We're Interested To See How Olink Holding (NASDAQ:OLK) Uses Its Cash Hoard To Grow

Jul 04

A Look At The Intrinsic Value Of Olink Holding AB (publ) (NASDAQ:OLK)

Jun 13

At US$21.02, Is It Time To Put Olink Holding AB (publ) (NASDAQ:OLK) On Your Watch List?

May 23

Olink Holding (NASDAQ:OLK) Is In A Strong Position To Grow Its Business

Mar 20

Calculating The Intrinsic Value Of Olink Holding AB (publ) (NASDAQ:OLK)

Dec 31

Olink Holding partners with Discovery Life Sciences to establish commercial platform

Sep 20

Olink Holding AB (publ) (NASDAQ:OLK) Just Reported, And Analysts Assigned A US$29.75 Price Target

Feb 17

Companies Like Olink Holding (NASDAQ:OLK) Can Afford To Invest In Growth

Jun 25

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 OLK 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: OLK 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

Olink Holding 시장 대비 배당 수익률

OLK 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (OLK)	n/a
시장 하위 25% (US)	1.4%
시장 상위 25% (US)	4.3%
업계 평균 (Life Sciences)	0.3%
애널리스트 예측 (OLK) (최대 3년)	n/a

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 OLK 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 OLK 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 OLK 의 지급 비율을 계산하기에는 데이터가 부족합니다.

주주에 대한 현금 배당금

현금 흐름 범위: OLK 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

This company listing is no longer active

Olink Holding 배당금

배당금 기준 확인 0/6

주요 정보

최근 배당금 업데이트

Recent updates

Olink Holding AB (publ)(NasdaqGM:OLK) dropped from NASDAQ Composite Index

Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others.

Revenues Tell The Story For Olink Holding AB (publ) (NASDAQ:OLK)

Olink® Target 48 Immune Surveillance Panel – the Next Frontier in Immune Biomarker Profiling with Absolute Confidence

Researchers Use Olink®? Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Olink Holding AB (publ) (NASDAQ:OLK) Just Reported And Analysts Have Been Cutting Their Estimates

Forecast breakeven date pushed back to 2025

Full year 2023 earnings: EPS and revenues miss analyst expectations

Olink Holding AB (publ), Annual General Meeting, Apr 19, 2024

Olink Holding AB Announces Promotion of Maria Liminga Björk to Chief Research and Development Officer

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Olink Holding AB (publ) to Report Q3, 2023 Results on Nov 15, 2023

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

Is It Time To Consider Buying Olink Holding AB (publ) (NASDAQ:OLK)?

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

Thermo Fisher Scientific Inc. (NYSE:TMO) proposed an offer to acquire Olink Holding AB (publ) (NasdaqGM:OLK) from Summa Equity AB and others for approximately $3.3 billion.

New major risk - Share price stability

Olink Holding AB (publ) Demonstrates the Power of the Olink Explore Platform for Driving Impactful Proteogenomic Studies At the Population Scale

Olink Holding AB (Publ) Announces the Introduction of Olink(R) Target 48 Mouse Cytokine Panel

Chief Scientific Officer notifies of intention to sell stock

Forecast breakeven date pushed back to 2025

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Olink Holding AB (Publ) Reiterates Revenue Guidance for the Full Year 2023

Olink Holding AB (publ) to Report Q2, 2023 Results on Aug 09, 2023

Olink Holding AB (Publ) Announces the Introduction of Olink(R) Explore Ht

We're Interested To See How Olink Holding (NASDAQ:OLK) Uses Its Cash Hoard To Grow

Now 23% undervalued after recent price drop

A Look At The Intrinsic Value Of Olink Holding AB (publ) (NASDAQ:OLK)

Now 21% undervalued after recent price drop

At US$21.02, Is It Time To Put Olink Holding AB (publ) (NASDAQ:OLK) On Your Watch List?

Consensus EPS estimates fall by 18%

Consensus EPS estimates fall by 18%

Price target increased by 8.7% to US$25.00

Olink Holding AB (Publ) Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.11 loss per share (vs US$0.10 loss in 1Q 2022)

Full year 2022 earnings: Revenues in line with analyst expectations

Olink Holding (NASDAQ:OLK) Is In A Strong Position To Grow Its Business

Consensus estimates of losses per share improve by 21%

Full year 2022 earnings: EPS exceeds analyst expectations

Olink Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 21, 2023

Calculating The Intrinsic Value Of Olink Holding AB (publ) (NASDAQ:OLK)

Price target increased to US$22.00

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

High number of new and inexperienced directors

Olink® Flex, A New, Unique and Fully Flexible Low-Plex Proteomics Solution Using Absolute Quantification

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Olink Holding AB (publ) Provides Earnings Guidance for the Full Year 2022

Olink Holding AB (Publ) Announces the Launch of Olink(R) Insight

Consensus forecasts updated

Olink Holding AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

Olink Holding partners with Discovery Life Sciences to establish commercial platform

We're Hopeful That Olink Holding (NASDAQ:OLK) Will Use Its Cash Wisely

Olink Holding AB (Publ) Announces Management Appointments

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Olink Holding AB (Publ) Provides Revenue Guidance for the Fiscal Year 2022

Olink GAAP EPS of -$0.04, revenue of $27.5M; reaffirms FY22 guidance

Olink Holding AB (publ) to Report Q2, 2022 Results on Aug 11, 2022

Release of Olink Analyze 3.1 Streamlines Proteomic Analysis to Connect Data to Biological Insight

Consensus forecasts updated

We're Not Very Worried About Olink Holding's (NASDAQ:OLK) Cash Burn Rate

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Olink Holding Plans Strong 2022 Spending Amid Growth Slowdown

Olink Holding AB (publ) Provides Revenue Guidance for the Year 2022

Forecast breakeven date moved forward to 2023

High number of new and inexperienced directors

Olink Holding AB (publ) to Report Q1, 2022 Results on May 12, 2022

Forecast to breakeven in 2024

Olink Holding AB (publ) Announces Board Appointments

Consensus EPS estimates fall by 68%

Olink Holding AB (publ) (NASDAQ:OLK) Just Reported, And Analysts Assigned A US$29.75 Price Target

Full year 2021 earnings: Revenues exceed analyst expectations

Olink Holding AB (publ) Provides Revenue Guidance for 2022